David Loew, formerly executive vice president of Sanofi Pasteur, Sanofi's vaccines division, was appointed CEO of fellow French firm Ipsen on the 28th…
These are worrying times for iconic French mid-cap Ipsen. Trials for palovarotene, a treatment for rare bone disorders, have been plagued by setbacks,…